Psychemedics Announces a “Vaping Panel” to Detect and Deter the Use of Marijuana, CBD and Nicotine ACTON, Mass., May 05, 2020 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world leader and pioneer in detecting drugs of abuse using hair analysis, today introduced a Vaping Panel to...

BioCorRx Announces Award of $2.8 Million, the Second Tranche of a NIDA Grant for the Development of BICX102, a Sustained Release Naltrexone Implant for the Treatment of Opioid Use Disorder ANAHEIM, CA, Jan. 30, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE --BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of advanced solutions in the treatment of substance use...

Trevena Announces Initiation of Proof-of-Concept Study for TRV734 for Potential Treatment of Opioid Use Disorder CHESTERBROOK, Pa., Dec. 23, 2019 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with...

Caron Experts Urge Parents Not to Minimize Dangers of Vaping, Advocate for Immediate Intervention and a Zero Tolerance Policy Wernersville, PA, Dec. 17, 2018 (GLOBE NEWSWIRE) -- The 2018 Monitoring the Future results released today by the University of Michigan and the National Institute on Drug Abuse (NIDA) are cause for...